Investment, Funding & Disinvestments

The consignment includes 6,000 personal protective equipment (PPE) kits, 60 powered air-purifying respirators, 30,000 N95 masks, and more than 86,000 sample transport kits.

The renovation was completed through a partnership with medical supplies distributor Surgipharm Ltd and healthcare products company BSN-ESSITY, which supported the facility’s transformation into a modern treatment environment.

Vir could also receive up to US$45 million in near-term preclinical milestone payments and up to US$1.74 billion in potential development, regulatory, and commercial milestones.

The agreement also includes US$35 million in preclinical milestone payments, with additional development and commercial milestones bringing the total potential deal value to nearly US$1.2 billion.

Pfizer will assume responsibility for subsequent clinical development, manufacturing, regulatory submissions and commercialisation after the discovery phase.

The firm secured capital from a broad investor base, including medical institutions, pension funds, family offices, sovereign wealth funds and university endowments.

The facility includes ISO Class 8 cleanrooms, a secondary packaging area, quality control laboratories and a microbiology laboratory equipped for sterility testing.

Unlike conventional airway surgery, the tubeless technique keeps a standard breathing tube out of the surgical field, improving visibility and access to the affected area.

The acquisition will enable Cotecna to serve pharmaceutical companies with a broader range of regulatory compliant testing services, while improving its capacity to respond to customer requirements across key markets.

The approach will allow Cinfa to build its regional operations incrementally while developing expertise and infrastructure within the UAE.